Brian Andrew Van Tine (Brian A Van Tine, Brian Van Tine, Brian Van Tine)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 67

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

Cell death & disease

Washington Univeristy in St Louis

University of Alabama at Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington Univeristy in St Louis

United States

Associate Prof. :: Internal Medicine

Education History

University of Alabama at Birmingham

United States

PHD :: Pathology

Publications

Brian Andrew Van Tine, Sasha Haarberg
Is it Time to Resist using RECIST as a Primary Endpoint for Rare Tumors Trials? Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rony Takchi, Bethany C Prudner, Qingqing Gong, Takaomi Hagi, Kenneth F Newcomer, Linda X Jin, Suwanna Vangveravong, Brian Andrew Van Tine, William G Hawkins, Dirk Spitzer
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress. Cell death & disease 15 (5) (2024)
Muhammad A Saeed, Bo Peng, Kevin Kim, Kavita Rawat, Lindsey M Kuehm, Zoe R Siegel, Ariel Borkowski, Nabih Habib, Brian Andrew Van Tine, Nadeem A Sheikh, Vu Tuyen, Daniel L J Thorek, Todd A Fehniger, Russell K Pachynski
High dimensional analyses reveal IL-15 enhances activation of Sipuleucel-T lymphocyte subsets and reverses immunoresistance. Cancer immunology research (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Rony Takchi, Bethany C Prudner, Qingqing Gong, Takaomi Hagi, Kenneth F Newcomer, Linda X Jin, Suwanna Vangveravong, Brian Andrew Van Tine, William G Hawkins, Dirk Spitzer
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress. Cell death & disease 15 (5) (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Muhammad A Saeed, Bo Peng, Kevin Kim, Kavita Rawat, Lindsey M Kuehm, Zoe R Siegel, Ariel Borkowski, Nabih Habib, Brian Andrew Van Tine, Nadeem A Sheikh, Vu Tuyen, Daniel L J Thorek, Todd A Fehniger, Russell K Pachynski
High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance. Cancer immunology research 12 (5) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Gregory M Cote, Anthony P Conley, Steven Attia, Brian Andrew Van Tine, Mahesh Seetharam, Yen-Lin Chen, Zarina Gafoor, Christopher Heery, Cesar Pico-Navarro, Tatiana Adams
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma. Cancer (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rony Takchi, Bethany C Prudner, Qingqing Gong, Takaomi Hagi, Kenneth F Newcomer, Linda X Jin, Suwanna Vangveravong, Brian Andrew Van Tine, William G Hawkins, Dirk Spitzer
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress. Cell death & disease 15 (5) (2024)
Rony Takchi, Bethany C Prudner, Qingqing Gong, Takaomi Hagi, Kenneth F Newcomer, Linda X Jin, Suwanna Vangveravong, Brian Andrew Van Tine, William G Hawkins, Dirk Spitzer
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress. Cell death & disease 15 (5) (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Muhammad A Saeed, Bo Peng, Kevin Kim, Kavita Rawat, Lindsey M Kuehm, Zoe R Siegel, Ariel Borkowski, Nabih Habib, Brian Andrew Van Tine, Nadeem A Sheikh, Vu Tuyen, Daniel L J Thorek, Todd A Fehniger, Russell K Pachynski
High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance. Cancer immunology research 12 (5) (2024)
Natalie K Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L Siontis, Janet Yoon, Sant Chawla, Mohammed M Milhem, Varun V Monga, Keith M Skubitz, John Charlson, Angela C Hirbe, Mia C Weiss, Brian Andrew Van Tine, Mark Agulnik
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. Journal of clinical medicine 12 (7) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Nam Bui, Hilary Dietz, Sheima Farag, Angela C Hirbe, Michael J Wagner, Brian Andrew Van Tine, Kristen Ganjoo, Robin L Jones, Vicki L Keedy, Elizabeth J Davis
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma. Cancers 15 (9) (2023)
Mia C Weiss, Vanessa Eulo, Brian Andrew Van Tine
To Quiesce or Senesce, that is the question for Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nam Bui, Hilary Dietz, Sheima Farag, Angela C Hirbe, Michael J Wagner, Brian Andrew Van Tine, Kristen Ganjoo, Robin L Jones, Vicki L Keedy, Elizabeth J Davis
A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma. Cancers 15 (9) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine (2023)
Leonard C Rogers, Jeff C Kremer, Caitlyn B Brashears, Zongtao Lin, Zhixian Sherrie Hu, Alliny Cristiny da Silva Bastos, Adriana Baker, Nicole Fettig, Dong Zhou, Kooresh I Shoghi, Carina A Dehner, John S A Chrisinger, John S Bomalaski, Benjamin A Garcia, Toshinao Oyama, Eileen P White, Brian Andrew Van Tine
Discovery and targeting of a noncanonical mechanism of sarcoma resistance to ADI-PEG20 mediated by the microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martín-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Richard F Riedel, Silvia Stacchiotti, Elizabeth Trice Loggers, Kristen N Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier García Del Muro Solans, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F Mulcahy, Charles Forscher, Nicolas Penel, Scott H Okuno, Anthony D Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore D F Lapeire, Jean Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K Schwartz, James L Chen, Hari Deshpande, Elizabeth J Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F Meyer, Margaret von Mehren, Brian Andrew Van Tine, Katharina S Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T J Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A Dickson, Dayana Michel, Chang-Ting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R Van Domelen, Christopher J Walker, Hua Chang, Yosef Landesman, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Steven Attia
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Anna C Greene, Brian Andrew Van Tine
Are the Pieces Starting to Come Together for Management of Desmoid Tumors? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A single-arm phase 2 trial of Sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Devon Miller, Jonathan A Livingston, Yeonhee Park, Kristi Posey, Sonia Godbole, Keith M Skubitz, Steven I Robinson, Mark Agulnik, Lara E Davis, Brian Andrew Van Tine, Angela C Hirbe, Amanda Parkes
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer medicine 11 (18) (2022)
Hua Sun, Song Cao, R Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C Wendl, Sherri R Davies, Matthew H Bailey, Tina M Primeau, Jeremy Hoog, Jacqueline L Mudd, Dennis A Dean, Rajesh Patidar, Li Chen, Matthew A Wyczalkowski, Reyka G Jayasinghe, Fernanda Martins Rodrigues, Nadezhda V Terekhanova, Yize Li, Kian-Huat Lim, Andrea Wang-Gillam, Brian Andrew Van Tine, Cynthia X Ma, Rebecca Aft, Katherine C Fuh, Julie K Schwarz, Jose P Zevallos, Sidharth V Puram, John F Dipersio, null null, Brandi Davis-Dusenbery, Matthew J Ellis, Michael T Lewis, Michael A Davies, Meenhard Herylyn, Bingliang Fang, Jack A Roth, Alana L Welm, Bryan E Welm, Funda Meric-Bernstam, Feng Chen, Ryan C Fields, Shunqiang Li, Ramaswamy Govindan, James H Doroshow, Jeffrey A Moscow, Yvonne A Evrard, Jeffrey H Chuang, Benjamin J Raphael, Li Ding
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. Nature communications 13 (1) (2022)
Brian Andrew Van Tine, Anders Krarup-Hansen, Lisa M Hess, Albiruni R Abdul Razak, Victoria Soldatenkova, Jennifer Wright, Se Hoon Park
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial. Rare tumors 14 (2022)
Caitlyn B Brashears, Bethany C Prudner, Richa Rathore, Katharine E Caldwell, Carina A Dehner, Jane L Buchanan, Sara E S Lange, Neal Poulin, Jennifer K Sehn, Jason Roszik, Dirk Spitzer, Kevin B Jones, Regis O'Keefe, Torsten O Nielsen, Eric B Taylor, Jason M Held, William Hawkins, Brian Andrew Van Tine
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Melissa A Reimers, Jennifer K Sehn, Brian Andrew Van Tine, Zachary L Smith
Primary Prostatic Synovial Sarcoma With Pulmonary Metastases Identified by Routine Next-Generation Sequencing. JCO precision oncology 5 (2022)
Brian Andrew Van Tine, Costas Andreas Lyssiotis
In an Era of ctDNA, Is Metabolomics the New Kid on the Block? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Lawrence Liu, Carina Dehner, Nikhil Grandhi, Yang Lyu, Dana C Borcherding, John S A Chrisinger, Xiao Zhang, Jingqin Luo, Yu Tao, Amanda Parkes, Nam Q Bui, Elizabeth J Davis, Mohammed M Milhem, Varun V Monga, Mia Weiss, Brian Andrew Van Tine, Angela C Hirbe
The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis. Genes 13 (11) (2022)
Alexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, E Andres Houseman, Shan Zhong, Jaegil Kim, Michael Nathenson, Thomas Faitg, Mary Woessner, David C Turner, Aisha N Hasan, John Glod, Rosandra N Kaplan, Sandra P D' Angelo, Dejka M Araujo, Warren A Chow, Mihaela Druta, George D Demetri, Brian Andrew Van Tine, Stephan A Grupp, Gregg D Fine, Ioanna Eleftheriadou
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma. Nature communications 13 (1) (2022)
Nikolaos A Trikalinos, John S A Chrisinger, Brian Andrew Van Tine
Common Pitfalls in Ewing Sarcoma and Desmoplastic Small Round Cell Tumor Diagnosis Seen in a Study of 115 Cases. Medical sciences (Basel, Switzerland) 9 (4) (2021)
Mia C Weiss, Vanessa Eulo, Brian Andrew Van Tine
Truly Man's Best Friend: Canine Cancers Drive Drug Repurposing in Osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Sant P Chawla, Brian Andrew Van Tine, Seth M Pollack, Kristen N Ganjoo, Anthony D Elias, Richard F Riedel, Steven Attia, Edwin Choy, Scott H Okuno, Mark Agulnik, Margaret von Mehren, Michael B Livingston, Vicki L Keedy, Claire F Verschraegen, Tony Philip, G Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen, Robert G Maki
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Berta Grigorian, Anita N Schmid, Shihe Hou, Katherine Harris, David J Kwiatkowski, Neil P Desai, Mark A Dickson
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, Margaret von Mehren, Scott M Schuetze, Brian Andrew Van Tine, Robert L Coleman, Roland Knoblauch, Spyros Triantos, Peter Hu, Waleed Shalaby, Tracy McGowan, Bradley J Monk, George D Demetri
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer medicine 10 (11) (2021)
Bernd Kasper, Annie Achee, Kathrin Schuster, Roger Wilson, Gerard van Oortmerssen, Rebecca A Gladdy, Matthew L Hemming, Paul Huang, Matthew Ingham, Robin L Jones, Seth M Pollack, Denise Reinke, Roberta Sanfilippo, Scott M Schuetze, Neeta Somaiah, Brian Andrew Van Tine, Breelyn Wilky, Scott Okuno, Jonathan C Trent
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN). Cancers 13 (4) (2021)
Brian Andrew Van Tine, Angela C Hirbe, Peter Oppelt, Ashley E Frith, Richa Rathore, Joshua D Mitchell, Fei Wan, Shellie Berry, Michele Landeau, George A Heberton, John Gorcsan, Peter R Huntjens, Yoku Soyama, Justin M Vader, Jose A Alvarez-Cardona, Kathleen W Zhang, Daniel J Lenihan, Ronald J Krone
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Hua Sun, Song Cao, R Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C Wendl, Sherri R Davies, Matthew H Bailey, Tina M Primeau, Jeremy Hoog, Jacqueline L Mudd, Dennis A Dean, Rajesh Patidar, Li Chen, Matthew A Wyczalkowski, Reyka G Jayasinghe, Fernanda Martins Rodrigues, Nadezhda V Terekhanova, Yize Li, Kian-Huat Lim, Andrea Wang-Gillam, Brian Andrew Van Tine, Cynthia X Ma, Rebecca Aft, Katherine C Fuh, Julie K Schwarz, Jose P Zevallos, Sidharth V Puram, John F Dipersio, null null, Brandi Davis-Dusenbery, Matthew J Ellis, Michael T Lewis, Michael A Davies, Meenhard Herylyn, Bingliang Fang, Jack A Roth, Alana L Welm, Bryan E Welm, Funda Meric-Bernstam, Feng Chen, Ryan C Fields, Shunqiang Li, Ramaswamy Govindan, James H Doroshow, Jeffrey A Moscow, Yvonne A Evrard, Jeffrey H Chuang, Benjamin J Raphael, Li Ding
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nature communications 12 (1) (2021)
Robin L Jones, Andrew J Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian Andrew Van Tine, Javier Martín-Broto, Patrick M Peterson, Jennifer Wright, William D Tap
Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Gulam A Manji, Brian Andrew Van Tine, Shing M Lee, Alexander G Raufi, Ilenia Pellicciotta, Angela C Hirbe, Jaya Pradhan, Andrew X Chen, Raul Rabadan, Gary K Schwartz
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Brian Andrew Van Tine, Mia C Weiss, Angela C Hirbe, Peter J Oppelt, Sarah Abaricia, Kathryn Trinkaus, Jingqin Luo, Shellie Berry, Tyler Ruff, Cheryl Callahan, Jacqui Toensikoetter, Jessica Ley, Marilyn J Siegel, Farrokh Dehdashti, Barry A Siegel, Douglas R Adkins
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma. Rare tumors 13 (2021)
Leonard C Rogers, Jing Zhou, Adriana Baker, Charles R Schutt, Prashanta K Panda, Brian Andrew Van Tine
Intracellular arginine-dependent translation sensor reveals the dynamics of arginine starvation response and resistance in ASS1-negative cells. Cancer & metabolism 9 (1) (2021)
Richa Rathore, Brian Andrew Van Tine
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies. Journal of clinical medicine 10 (6) (2021)
Adem Aktas, Daniel Probst, Brian Andrew Van Tine, Kathryn Marlow
Hepatic epithelioid hemangioendothelioma associated with acute disseminated encephalomyelitis by a possible paraneoplastic process. Rare tumors 12 (2020)
Mrinal M Gounder, Priscilla Merriam, Ravin Ratan, Shreyaskumar R Patel, Rashmi Chugh, Victor M Villalobos, Mark Thornton, Brian Andrew Van Tine, Amr H Abdelhamid, Jennifer Whalen, Jay Yang, Anand Rajarethinam, Mei Sheng Duh, Priyanka J Bobbili, Lynn Huynh, Todor I Totev, Angela K Lax, Shefali Agarwal, George D Demetri
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer 127 (8) (2020)
Javier Martín-Broto, David S Moura, Brian Andrew Van Tine
Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Neeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, Mohammed M Milhem, Elizabeth G Hill, Elizabeth Garrett-Mayer, Kent E Armeson, Scott M Schuetze, Christian F Meyer, Daniel Y Reuben, Anthony D Elias, William L Read, Sant P Chawla, Andrew S Kraft
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer 127 (6) (2020)
Caitlyn B Brashears, Meltem Barlin, William R Ehrhardt, Richa Rathore, Matthew Schultze, Shin-Chen Tzeng, Brian Andrew Van Tine, Jason M Held
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming. Cell death & disease 11 (8) (2020)
Javier Martín-Broto, Antonio López Pousa, Andrew S Brohl, Brian Andrew Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James S Hu, Gerard J Oakley, Hong Wang, Anna M Szpurka, Donna E Levy, Gary Mo, Matteo Ceccarelli, Robin L Jones
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Molecular cancer therapeutics 20 (1) (2020)
Seth M Pollack, Neeta Somaiah, Dejka M Araujo, Mihaela Druta, Brian Andrew Van Tine, Melissa A Burgess, Sant P Chawla, Mahesh Seetharam, Scott H Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States. Cancer medicine 9 (13) (2020)
Emily Z Keung, Melissa Burgess, Ruth Salazar, Edwin R Parra, Jaime Rodrigues-Canales, Vanessa Cilento, Brian Andrew Van Tine, Scott M Schuetze, Steven Attia, Richard F Riedel, James Hu, Scott H Okuno, Dennis A Priebat, Sujana Movva, Lara E Davis, Damon R Reed, Alexandre Reuben, Christina L Roland, Denise Reinke, Alexander J F Lazar, Wei-Lien Wang, Jennifer A Wargo, Hussein A Tawbi
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2020)
Bethany C Prudner, Richa Rathore, Anthony M Robinson, Abigail Godec, Samuel F Chang, William G Hawkins, Angela C Hirbe, Brian Andrew Van Tine
Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)
Shihong Zhang, Karan Kohli, R Graeme Black, Lu Yao, Sydney M Spadinger, Qianchuan He, Venu G Pillarisetty, Lee D Cranmer, Brian Andrew Van Tine, Cassian Yee, Robert H Pierce, Stanley R Riddell, Robin L Jones, Seth M Pollack
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer immunology research 7 (8) (2019)
Victor M Villalobos, Gary Mo, Mark Agulnik, Seth M Pollack, Daniel A Rushing, Arun Singh, Brian Andrew Van Tine, Rhian McNaughton, Rodney L Decker, Wei Zhang, Ashwin Shahir, Damien M Cronier
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma. Cancer medicine 9 (3) (2019)
Brian Andrew Van Tine, Mark Agulnik, Richard D Olson, Gerald M Walsh, Arthur Klausner, Nicole E Frank, Todd T Talley, Mohammed M Milhem
A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma. Cancer medicine 8 (6) (2019)

Brian Andrew Van Tine.css-eqlu8i{font-size:small;padding-left:4px;} (Brian A Van Tine, Brian Van Tine, Brian Van Tine)

Publication Activity (10 Years)

Top Topics

Top Venues

Brian Andrew Van Tine (Brian A Van Tine, Brian Van Tine, Brian Van Tine)